TG Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	74.08	179.89	92.93	102.3	298.89	553.44
Short-Term Investments	57.5	131.11	124.58	59.37	15.88	51.99
Cash & Short-Term Investments	131.58	311	217.51	161.68	314.76	605.43
Cash Growth	-61.42%	42.98%	34.53%	-48.63%	-48.01%	331.11%
Accounts Receivable	265.38	129.19	51.09	-	1.39	-
Receivables	265.38	129.19	51.09	-	1.39	-
Inventory	146.95	110.46	39.82	-	-	-
Other Current Assets	55.85	15.72	9.52	6.6	14.81	6.31
Total Current Assets	599.77	566.36	317.94	168.27	330.97	611.74
Property, Plant & Equipment	6.5	7.15	8.05	9.2	9.23	9.79
Long-Term Investments	48.76	0.81	-	12.4	35.53	-
Goodwill	-	-	-	0.8	0.8	0.8
Long-Term Deferred Charges	-	-	-	1.63	1.84	2.05
Other Long-Term Assets	3.37	3.37	3.59	1.27	1.26	1.26
Total Assets	1,025	577.69	329.59	193.57	379.63	625.64
Accounts Payable	61.64	26.3	29.27	42.02	50.89	37.01
Accrued Expenses	15.01	15.19	12.17	8.43	10.17	8.46
Current Portion of Long-Term Debt	0.82	0.66	0.36	0.24	1.34	23.12
Current Portion of Leases	1.07	1.16	1.45	1.58	1.44	1.67
Current Unearned Revenue	26.4	11.41	0.15	-	0.2	0.2
Other Current Liabilities	51.87	35.97	10.32	0.93	1.35	17.1
Total Current Liabilities	156.81	90.68	53.72	53.2	65.38	87.55
Long-Term Debt	245.34	244.43	100.12	71.14	66.79	7.72
Long-Term Leases	7.31	8.13	9.23	10.34	9.85	10.41
Long-Term Unearned Revenue	8.35	12.09	6.02	0.31	0.46	0.61
Total Liabilities	417.81	355.33	169.09	134.99	142.48	106.29
Common Stock	0.16	0.16	0.15	0.15	0.14	0.14
Additional Paid-In Capital	1,812	1,760	1,713	1,586	1,566	1,500
Retained Earnings	-1,105	-1,529	-1,553	-1,527	-1,329	-980.6
Treasury Stock	-100.23	-8.99	-0.23	-0.23	-0.23	-0.23
Shareholders' Equity	607.22	222.36	160.5	58.59	237.15	519.35
Total Liabilities & Equity	1,025	577.69	329.59	193.57	379.63	625.64
Total Debt	254.54	254.38	111.15	83.3	79.41	42.91
Net Cash (Debt)	-122.96	56.62	106.36	78.38	235.36	562.51
Net Cash Growth	-	-46.76%	35.70%	-66.70%	-58.16%	465.67%
Net Cash Per Share	-0.76	0.35	0.72	0.58	1.78	4.88
Filing Date Shares Outstanding	146.2	145.23	144.78	137.63	130.79	129.8
Total Common Shares Outstanding	142.68	143.99	141.79	137.65	131.22	129.79
Working Capital	442.96	475.68	264.22	115.07	265.58	524.19
Book Value Per Share	4.26	1.54	1.13	0.43	1.81	4.00
Tangible Book Value	607.22	222.36	160.5	57.79	236.35	518.55
Tangible Book Value Per Share	4.26	1.54	1.13	0.42	1.80	4.00

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.